Miguel, Juliana, Luiz Henrique Araujo, and Rodrigo Costa. “Cost-Effectiveness of Erlotinib Compared to Gefitinib for NSCLC With EGFR Mutations at the Inca”. Jornal Brasileiro de Economia da Saúde 12, no. 1 (April 20, 2020): 8–15. Accessed November 23, 2025. https://www.jbes.com.br/index.php/jbes/article/view/171.